|
|
|
|
|
Legal status
Patent expired
| (51) | INT.CL.: (2006.01) |
A61K 31/4402 A61K 31/4418 A61P 31/00 A61P 43/00 C07D 213/00 |
| (11) | Number of the document | 4780 |
| (13) | Kind of document | B |
| (21) | Application number | 2000 067 |
| (22) | Date of filing the application | 2000-07-14 |
| (41) | Date of publication of the application | 2000-11-27 |
| (45) | Date of publication of patent | 2001-04-25 |
| (86) | Number | PCT/US98/27382 |
| Date | 1998-12-22 |
| (87) | Number | WO 99/36404 |
| Date | 1999-07-22 |
| (30) | Number | Date | Country code |
| 071968 | 1998-01-20 | US |
| (71) |
BRISTOL-MYERS SQUIBB COMPANY,
Lawrenceville-Princeton Road, Princeton, New Jersey 08543-4000,
US
|
| (72) |
Janak SINGH, US
Madhusudhan PUDIPEDDI, US Mark D. LINDRUD, US |
| (73) |
Bristol-Myers Squibb Holdings Ireland,
Hinterbergstrasse 16, 6312 Steinhausen,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | BISULFATE SALT OF HIV PROTEASE INHIBITOR |
| Payment date | Validity (years) | Amount | |
| 2017-11-16 | 20 | 347.00 EUR |
| Patent expired | ||
| Invalidation date | 2018-12-22 |